Driving forward medical device development

2 Oct 2019, 4:57 p.m.

medical devices workshop

The NIHR GOSH BRC last month hosted an inaugural medical devices workshop, in partnership with the UCL Institute of Healthcare Engineering. 80 attendees, including clinicians and researchers at various career stages, came along to hear about the entire process of medical device development from inception of an idea to eventual implementation into the patient care pathway.

During a showcase session researchers introduced attendees to a range of devices that have been developed or are being developed at GOSH and UCL, explaining their development process and sharing tips and best practice. Exemplar projects highlighted include the FizzyO project and the GOSH DRIVE App developmemt

The sessions aiming to provide researchers with practical advice on how to navigate the complex process of device development an included talks on  from patents and design rights (led by William Burrel, Patent Attorney, D Young & Co) and new product regulations (led by Dr Alan McLeod, Managing Director, Health Innovation Support Limited).

There were also introductions from teams at NIHR, the UCL Translational Research Office, UCL Institute of Healthcare Engineering, NIHR, Medicines and Healthcare Products Regulatory Agency (MHRA), UCL Business and UCL Partners, who each outlined how their organisations can support clinicians and scientists in the development of medical devices.

The event brought also provided plenty of opportunity for networking between together clinicians and scientists with unmet medical needs problems, and engineers with the technical knowledge to help develop solutions.

This event was part of the NIHR GOSH BRC’s Translational Research and Enterprise Accelerator theme which builds on the BRC's extensive track record of clinical impact through translational innovation and aims to ensure research is rapidly translated into direct benefits for children at GOSH and worldwide.

NIHR launches £13.7m investment into brain tumour research

The National Institute for Health and Care Research (NIHR) has announced a £13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.

New consortium aims to help improve care for arthritis patients

A new UK-led research group, including Great Ormond Street Hospital and University College London, aims to improve the lives of children, young people and adults with arthritis by defining for the first time what being in ‘remission’ from arthritis truly

Update for patients and families on industrial action - December 2025

As you may be aware, some of our Resident Doctors will be taking part in planned industrial action from 7am on Wednesday 17 December to 7am on Monday 22 December.

‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-Cell leukaemia

A groundbreaking new treatment using gene-edited immune cells, developed at GOSH and UCL has shown promising results in helping children and adults fight a rare and aggressive cancer